Compounds > 7,7'-(carbonyl-bis(imino-n-methyl-4,2-pyrrolcarbonylimino(n-methyl-4,2-pyrrol)carbonylimino))-bis(1,3-naphthalenedisulfonic acid)
Page last updated: 2024-09-04

7,7'-(carbonyl-bis(imino-n-methyl-4,2-pyrrolcarbonylimino(n-methyl-4,2-pyrrol)carbonylimino))-bis(1,3-naphthalenedisulfonic acid) and Angiogenesis, Pathologic

7,7'-(carbonyl-bis(imino-n-methyl-4,2-pyrrolcarbonylimino(n-methyl-4,2-pyrrol)carbonylimino))-bis(1,3-naphthalenedisulfonic acid) has been researched along with Angiogenesis, Pathologic in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ciomei, M; Grandi, M; Mariani, M; Mongelli, N; Pastori, W; Sola, F1
Caiolfa, VR; Parola, AH; Pines, D; Pines, E; Zamai, M1
Barbanti-Brodano, G; Betti, M; Calza, N; Campioni, D; Caputo, A; Ciomei, M; Corallini, A; Presta, M; Rusnati, M; Sola, F; Zauli, G1
Barbanti-Brodano, G; Bompadre, S; Campioni, D; Caputo, A; Ciomei, M; Corallini, A; Ferrante, L; Leone, L; Montesi, M; Possati, L; Rocchetti, R; Sola, F; Talevi, S; Trabanelli, C1

Other Studies

4 other study(ies) available for 7,7'-(carbonyl-bis(imino-n-methyl-4,2-pyrrolcarbonylimino(n-methyl-4,2-pyrrol)carbonylimino))-bis(1,3-naphthalenedisulfonic acid) and Angiogenesis, Pathologic

ArticleYear
New sulfonated distamycin A derivatives with bFGF complexing activity.
    Biochemical pharmacology, 1994, Jan-20, Volume: 47, Issue:2

    Topics: 3T3 Cells; Animals; Binding, Competitive; Distamycins; Fibroblast Growth Factor 2; Mice; Mice, Inbred BALB C; Neovascularization, Pathologic; Phosphorylation; Structure-Activity Relationship; Sulfonic Acids; Suramin; Tyrosine

1994
Nature of interaction between basic fibroblast growth factor and the antiangiogenic drug 7,7-(Carbonyl-bis[imino-N-methyl-4, 2-pyrrolecarbonylimino[N-methyl-4,2-pyrrole]-carbonylimino] )bis-(1, 3-naphthalene disulfonate).
    Biophysical journal, 1998, Volume: 75, Issue:2

    Topics: Binding Sites; Chromatography, High Pressure Liquid; Crystallography, X-Ray; Distamycins; Fibroblast Growth Factor 2; Fluorescence Polarization; Humans; Kinetics; Least-Squares Analysis; Models, Molecular; Neovascularization, Pathologic; Protein Conformation; Recombinant Proteins

1998
Characterization of the effects of two polysulfonated distamycin A derivatives, PNU145156E and PNU153429, on HIV type 1 Tat protein.
    AIDS research and human retroviruses, 1998, Nov-20, Volume: 14, Issue:17

    Topics: Animals; Antiviral Agents; Distamycins; Female; Gene Products, tat; Glutathione Transferase; HeLa Cells; HIV-1; Humans; Mice; Mice, Inbred C3H; Neovascularization, Pathologic; Recombinant Fusion Proteins; Sulfates; tat Gene Products, Human Immunodeficiency Virus; Transcriptional Activation; Tumor Cells, Cultured

1998
Antiangiogenic, antitumoural and antimetastatic effects of two distamycin A derivatives with anti-HIV-1 Tat activity in a Kaposi's sarcoma-like murine model.
    Clinical & experimental metastasis, 1999, Volume: 17, Issue:7

    Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Distamycins; Drug Screening Assays, Antitumor; Female; Gene Products, tat; Genes, tat; HIV-1; Male; Mice; Mice, Nude; Mice, Transgenic; Minocycline; Neoplasm Metastasis; Neoplasm Proteins; Neoplasm Transplantation; Neovascularization, Pathologic; Sarcoma, Kaposi; tat Gene Products, Human Immunodeficiency Virus; Transfection

1999